Monday, June 1, 2020

Gilead's Remdesivir Shows Fair Improvement In Moderate COVID-19 Patients

Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who...

from NDTV News - World-news https://ift.tt/36PjXS6
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Opinion: Trump's European Snub: A U-Turn On Ukraine, Nixing NATO

As we mark three years of the Russian invasion of Ukraine, here's a look at Trump 2.0's Europe shakedown and his move to seek a rapp...